Merck
- The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of patients
- “We are very excited, we are moving very quickly with Merck onto phase 3 for this study,” Moderna CEO Stephane Bancel
© 2024 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.